 Atrial Fibrillation
"Atrial Fibrillation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Descriptor ID |
D001281
|
| MeSH Number(s) |
C14.280.067.198 C23.550.073.198
|
| Concept/Terms |
Atrial Fibrillation- Atrial Fibrillation
- Atrial Fibrillations
- Fibrillation, Atrial
- Fibrillations, Atrial
- Auricular Fibrillation
- Auricular Fibrillations
- Fibrillation, Auricular
- Fibrillations, Auricular
Persistent Atrial Fibrillation- Persistent Atrial Fibrillation
- Atrial Fibrillation, Persistent
- Atrial Fibrillations, Persistent
- Fibrillation, Persistent Atrial
- Fibrillations, Persistent Atrial
- Persistent Atrial Fibrillations
Familial Atrial Fibrillation- Familial Atrial Fibrillation
- Atrial Fibrillation, Familial
- Atrial Fibrillations, Familial
- Familial Atrial Fibrillations
- Fibrillation, Familial Atrial
- Fibrillations, Familial Atrial
Paroxysmal Atrial Fibrillation- Paroxysmal Atrial Fibrillation
- Atrial Fibrillation, Paroxysmal
- Atrial Fibrillations, Paroxysmal
- Fibrillation, Paroxysmal Atrial
- Fibrillations, Paroxysmal Atrial
- Paroxysmal Atrial Fibrillations
|
Below are MeSH descriptors whose meaning is more general than "Atrial Fibrillation".
Below are MeSH descriptors whose meaning is more specific than "Atrial Fibrillation".
This graph shows the total number of publications written about "Atrial Fibrillation" by people in this website by year, and whether "Atrial Fibrillation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 0 | 1 | | 1993 | 2 | 1 | 3 | | 1994 | 2 | 1 | 3 | | 1995 | 1 | 0 | 1 | | 1996 | 1 | 1 | 2 | | 1997 | 3 | 0 | 3 | | 1999 | 0 | 1 | 1 | | 2000 | 4 | 0 | 4 | | 2001 | 3 | 0 | 3 | | 2002 | 1 | 0 | 1 | | 2003 | 6 | 0 | 6 | | 2004 | 2 | 0 | 2 | | 2006 | 1 | 1 | 2 | | 2007 | 1 | 0 | 1 | | 2008 | 3 | 0 | 3 | | 2009 | 3 | 3 | 6 | | 2010 | 4 | 3 | 7 | | 2011 | 8 | 1 | 9 | | 2012 | 12 | 1 | 13 | | 2013 | 17 | 1 | 18 | | 2014 | 25 | 3 | 28 | | 2015 | 17 | 1 | 18 | | 2016 | 22 | 0 | 22 | | 2017 | 22 | 1 | 23 | | 2018 | 8 | 2 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Atrial Fibrillation" by people in Profiles.
-
Lin SZ, Crawford TC, Suarez-Pierre A, Magruder JT, Carter MV, Cameron DE, Whitman GJ, Lawton J, Baumgartner WA, Mandal K. A Novel Risk Score to Predict New Onset Atrial Fibrillation in Patients Undergoing Isolated Coronary Artery Bypass Grafting. Heart Surg Forum. 2018 12 13; 21(6):E489-E496.
-
Finks SW, Dobesh PP, Trujillo TC, Crossley GH. Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures. Cardiol Rev. 2018 Sep/Oct; 26(5):245-254.
-
Polnak JF, Delate T, Clark NP. The influence of fibrate initiation on INR and warfarin dose in patients receiving chronic warfarin therapy. J Thromb Thrombolysis. 2018 Aug; 46(2):264-270.
-
Roselli C, Chaffin MD, Weng LC, Aeschbacher S, Ahlberg G, Albert CM, Almgren P, Alonso A, Anderson CD, Aragam KG, Arking DE, Barnard J, Bartz TM, Benjamin EJ, Bihlmeyer NA, Bis JC, Bloom HL, Boerwinkle E, Bottinger EB, Brody JA, Calkins H, Campbell A, Cappola TP, Carlquist J, Chasman DI, Chen LY, Chen YI, Choi EK, Choi SH, Christophersen IE, Chung MK, Cole JW, Conen D, Cook J, Crijns HJ, Cutler MJ, Damrauer SM, Daniels BR, Darbar D, Delgado G, Denny JC, Dichgans M, Dörr M, Dudink EA, Dudley SC, Esa N, Esko T, Eskola M, Fatkin D, Felix SB, Ford I, Franco OH, Geelhoed B, Grewal RP, Gudnason V, Guo X, Gupta N, Gustafsson S, Gutmann R, Hamsten A, Harris TB, Hayward C, Heckbert SR, Hernesniemi J, Hocking LJ, Hofman A, Horimoto ARVR, Huang J, Huang PL, Huffman J, Ingelsson E, Ipek EG, Ito K, Jimenez-Conde J, Johnson R, Jukema JW, Kääb S, Kähönen M, Kamatani Y, Kane JP, Kastrati A, Kathiresan S, Katschnig-Winter P, Kavousi M, Kessler T, Kietselaer BL, Kirchhof P, Kleber ME, Knight S, Krieger JE, Kubo M, Launer LJ, Laurikka J, Lehtimäki T, Leineweber K, Lemaitre RN, Li M, Lim HE, Lin HJ, Lin H, Lind L, Lindgren CM, Lokki ML, London B, Loos RJF, Low SK, Lu Y, Lyytikäinen LP, Macfarlane PW, Magnusson PK, Mahajan A, Malik R, Mansur AJ, Marcus GM, Margolin L, Margulies KB, März W, McManus DD, Melander O, Mohanty S, Montgomery JA, Morley MP, Morris AP, Müller-Nurasyid M, Natale A, Nazarian S, Neumann B, Newton-Cheh C, Niemeijer MN, Nikus K, Nilsson P, Noordam R, Oellers H, Olesen MS, Orho-Melander M, Padmanabhan S, Pak HN, Paré G, Pedersen NL, Pera J, Pereira A, Porteous D, Psaty BM, Pulit SL, Pullinger CR, Rader DJ, Refsgaard L, Ribasés M, Ridker PM, Rienstra M, Risch L, Roden DM, Rosand J, Rosenberg MA, Rost N, Rotter JI, Saba S, Sandhu RK, Schnabel RB, Schramm K, Schunkert H, Schurman C, Scott SA, Seppälä I, Shaffer C, Shah S, Shalaby AA, Shim J, Shoemaker MB, Siland JE, Sinisalo J, Sinner MF, Slowik A, Smith AV, Smith BH, Smith JG, Smith JD, Smith NL, Soliman EZ, Sotoodehnia N, Stricker BH, Sun A, Sun H, Svendsen JH, Tanaka T, Tanriverdi K, Taylor KD, Teder-Laving M, Teumer A, Thériault S, Trompet S, Tucker NR, Tveit A, Uitterlinden AG, Van Der Harst P, Van Gelder IC, Van Wagoner DR, Verweij N, Vlachopoulou E, Völker U, Wang B, Weeke PE, Weijs B, Weiss R, Weiss S, Wells QS, Wiggins KL, Wong JA, Woo D, Worrall BB, Yang PS, Yao J, Yoneda ZT, Zeller T, Zeng L, Lubitz SA, Lunetta KL, Ellinor PT. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018 06 11; 50(9):1225-1233.
-
Rosenberg MA, Shores MM, Matsumoto AM, Bužková P, Lange LA, Kronmal RA, Heckbert SR, Mukamal KJ. Serum androgens and risk of atrial fibrillation in older men: The Cardiovascular Health Study. Clin Cardiol. 2018 Jun; 41(6):830-836.
-
Durheim MT, Holmes DN, Blanco RG, Allen LA, Chan PS, Freeman JV, Fonarow GC, Go AS, Hylek EM, Mahaffey KW, Pokorney SD, Reiffel JA, Singer DE, Peterson ED, Piccini JP. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Heart. 2018 11; 104(22):1850-1858.
-
Raparelli V, Pastori D, Pignataro SF, Vestri AR, Pignatelli P, Cangemi R, Proietti M, Davì G, Hiatt WR, Lip GYH, Corazza GR, Perticone F, Violi F, Basili S. Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study. Intern Emerg Med. 2018 08; 13(5):651-660.
-
Lubitz SA, Khurshid S, Weng LC, Doros G, Keach JW, Gao Q, Gehi AK, Hsu JC, Reynolds MR, Turakhia MP, Maddox TM. Predictors of oral anticoagulant non-prescription in patients with atrial fibrillation and elevated stroke risk. Am Heart J. 2018 06; 200:24-31.
-
Linnebur SA, Hanlon JT. Drug Interactions With Non-Vitamin K Oral Anticoagulants. JAMA. 2018 02 27; 319(8):828-829.
-
Phelps E, Delate T, Witt DM, Shaw PB, McCool KH, Clark NP. Effect of increased time in the therapeutic range on atrial fibrillation outcomes within a centralized anticoagulation service. Thromb Res. 2018 03; 163:54-59.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|